Meeting Overview
0+
Industry Speaker
0+
Professional Visitors
0+
Special Topic
2+
Featured Event
Highlights
- •Leverage craftsmanship and production capacity to unlock market potential in Asia-Pacific, particularly Southeast Asia.
Forum Schedule
9/22
BPD Main Forum (Session 1)
AM
09:00-09:10
Opening Remarks
09:10-09:40
Dialogue: A New Paradigm for the Globalization of China's Biopharmaceuticals: From Process Innovation to Ecosystem Collaboration
09:40-10:20
Panel: Ecosystem Collaboration in Global Supply Chain Restructuring: Resilience, Efficiency, and Cross-Border Integration
10:20-10:40
Networking Break
10:40-11:10
Keynote: From Global to Asia: Regionalization Strategy and Market Entry Pathways for Biopharmaceutical Companies
11:10-11:30
Keynote speech: Commercial Effectiveness for Biopharmaceuticals Entering ASEAN
Speaker: Shri Sarkar, Partner at L.E.K. Consulting
11:30-12:10
Panel: Southeast Asia Opportunities for Innovative Biologics: Aligning Demand, Localizing Technology, and Forming Commercial Partnerships
Panelist: Bo Ying, CEO of Abogen Biosciences
12:00-13:00
Lunch & Networking
XDC / BsAb-TCE
XDC (Session 1)
13:00-13:20
Keynote: Global Technology Trends and Current Competitive Landscape of XDC
13:20-13:40
Keynote: XDC Optimization Strategies for Linker and Payload Screening
13:40-14:00
Keynote Speech: Regulatory Considerations for Manufacturing and Controls of ADCs
Speaker: Audrey Jia, former FDA OBP CMC reviewer; Founder of Wonderfulland Regulatory Consulting
14:00-14:50
Panel Discussion: Latest Advances in Antibody Drug Research for Tumor Therapy
14:50-15:20
Tea break & Networking
BsAb-TCE (Session 1)
15:20-15:40
Keynote Speech: mRNA Reshapes the TCE Development Paradigm
Speaker: Bo Ying, CEO of Abogen Biosciences
15:40-16:00
Keynote Speech: Exploring the Clinical Application of TCE in Oncology
16:00-17:00
Panel Discussion: CMC Challenges in High-Expression Construct Development, Purification Processes, and Rigorous Aggregate Control
Regulations and Market Access in Southeast Asia
Regulation and Market Access in Southeast Asia (Session 2)
13:00-13:20
Keynote speech: Indonesia's Evolving Pharmaceutical Landscape: Regulatory Readiness and Market Access for Innovative Therapies
Speaker: Shanti Marlina Sibuea, BPOM, Acting Director of Production Control for Drugs, Narcotics, Psychotropics, and Precursors
13:20-13:40
Keynote Address: Advancing Cell and Gene Therapy and Clinical Research in Saudi Arabia: SFDA Regulations, Market Access, and Implementation Insights
Speaker: Abdulaziz AlSayyari, BiSynergic, Managing Partner
13:40-14:00
Keynote Speech: Market Access Strategy in Singapore from an MNC Perspective
Speaker: Jun Feng, J&J, APAC Market Access Director
14:00-14:20
Keynote Speech: Commercializing Gene Therapy Outside the US and Europe: Lessons from Thailand
Speaker: Veerachat Petpisit, Founder of Nouvogenes Therapeutics
14:20-14:35
Keynote Speech: Geopolitics, Supply Chains, and Market Access: Building a Resilient Biopharma Policy in India
Speaker: Gaurav Arora, Chief Commercial Officer, BioPharma Centrum
14:35-14:50
Dialogue: Regulatory pathways for biologic approval in India
Panelists: Gaurav Arora, Chief Commercial Officer, BioPharma Centrum; Vipul Doshi, Chief Quality and Compliance Officer and Global Head of Pharmacovigilance, Zydus Lifesciences
14:50-15:20
Tea break & Networking
15:20-15:35
Keynote Speech: Overview of Pharmaceutical Regulatory Policies in Malaysia
Cell Therapy
Cell Therapy (Session 2)
15:35-15:55
Keynote Speech: From Lab to Bedside: Navigating Unmet Needs in Late-Stage Solid Tumor Treatment with Cost-Effective CAR-T Therapy
Speaker: He Ting, CEO, IMUNOPHARM Technology
15:55-16:15
Keynote Address: Global Registration and Strategic Deployment of Innovative iPSC Cell Therapies
Speaker: Jing Fan, Hopstem therapeutics, Founder & CEO
16:15-16:35
Keynote: Engineering iPSCs for Efficient Industrial-Scale Cell Therapy Manufacturing
Speaker: Yen CHOO, NTU Lee Kong Chian School of Medicine, Associate Professor of Stem Cell Science and Regenerative Medicine
16:35-17:15
Panel Discussion: Global Development and Innovation Opportunities in Cell Therapy
Panelists: IASO; Frank Su, CEO of TCRCure; Xiaoming Peng, CEO of Lion TCR
9/23
AI for Pharmaceuticals
AM
09:00-09:20
Keynote: AI Applications in Molecular Design and Target Discovery
Speaker: Lipeng Lai, XtalPi, Co-Founder & CIO
09:20-09:40
Keynote Speech: Harnessing Organoids and AI for Next-Generation Targeted Drug Discovery
Speaker: Haisheng Zhang, Signet Therapeutics, Founder & CEO
09:40-10:00
Keynote: Regulatory Compliance for AI in Pharmaceutical R&D
10:00-10:20
Keynote: AI-Driven Quality Control and Automated Data Analysis Platform
10:20-10:50
Networking
10:50-11:10
Keynote: Digital Twins and Intelligent Bioreactors
11:10-12:00
Panel Discussion: Adapting AI Algorithms to the Complexity and Variability of Biopharma CMC Workflows
Advanced Technology
PM
13:00-13:20
Keynote Speech: Regulatory CMC Considerations for Biologics Technology Transfer
Speaker: Poh Jeff, Gilead, Regulatory Affairs CMC Lead
13:20-13:40
Keynote: Key Considerations and Challenges in Bispecific Antibody Purification
Speaker: Wei Zhang, BTI, Principal Scientist & Group Leader, Downstream Processing
13:40-14:00
Keynote Speech: The Role of Digitalization and Automation in Manufacturing Advanced Therapy Medicinal Products
Speaker: Vipul Doshi, Chief Quality and Compliance Officer, Global Head of Pharmacovigilance at Zydus Lifesciences
14:00-14:20
Keynote Speech: Challenges in Large-Scale Production and Technology Transfer
14:20-14:40
Keynote Speech: Advancements in Next-Generation Continuous Manufacturing Processes
14:40-15:00
Keynote: Innovations in Cell Culture Technologies – Serum-Free Media and High-Expression Cell Line Development
15:00-16:00
Panel Discussion: Global Regulations and Best Practices for Process Characterization and Validation
PM
13:00-14:00
Panel Discussion: Common Challenges and Tailored Solutions for CMC Across Technology Platforms
14:00-14:20
Keynote Address: Comprehensive Strategies and Compliance Boundaries for Impurity Control and Residuals
14:20-14:40
Keynote speech: Implementing Soft Sensors in Fermentation Processes: A Practical Approach to Real-Time Monitoring and Process Optimization
Speaker: Junita Dwi Andhini, Bio Farma, QA Engineer
14:40-15:00
Keynote Speech: PEG-Free LNPs for Targeted mRNA Vaccine Delivery
Speaker: Yi Yan, BTI, A*STAR, Distinguished Principal Scientist
15:00-15:20
Keynote: Harnessing Cell Surface Glycans for Therapeutics
Speaker: Andre Choo, BTI, A*STAR, Deputy Executive Director
15:20-15:40
Keynote Address: Innovative R&D Directions for Exosomes
Southeast Asia Cooperation Opportunities
AM
09:00-09:40
Panel Discussion: Southeast Asia Focus: How Innovative Biotechs Maximize R&D, Manufacturing, and Business Development Collaboration
Panelists: Ling Tong, BD VP/Head, Buchang BioPharma; Gang Qin, CEO, Gene Quantum; Vince Deng, Partner, Med-Fine Capital; Vijay P. Karwal, Managing Director, CBC Group; Lalit Baregama, CBO, Symbiotec Pharmalab
09:40-10:20
Panel Discussion: Regulation and Market Access for Biologics in Singapore and Southeast Asia
Panelists: Jin Shun, Managing Director at PharmaGend; Jun Feng, APAC Market Access Director at J&J; Daniel Lee, Head of Commercial at Menarini APAC
10:20-10:50
Networking
Small Nucleic Acids / Peptides / mRNA / Gene Therapy
AM
10:50-11:10
Keynote Speech: Superior Extrahepatic Delivery via the PNP Platform and Clinical Applications
Speaker: H. Fai Poon, CEO of Sirnaomics
11:10-11:30
Keynote: Synthesis and GMP Manufacturing of Cyclic and Specially Modified Peptides
Speaker: Liu Dou, CEO of Shenzhen Oralead Pharma
11:30-11:50
Keynote: High-Yield Vector Production, Downstream Purification Processes, and Critical QC Points for Gene Therapy
Speaker: Claire Zhang, Gritgen, CTO
12:00-13:00
Lunch & Networking
PM
13:00-14:00
Panel Discussion: Common Challenges and Tailored Solutions for CMC Across Technology Platforms
14:00-14:20
Keynote Address: Comprehensive Strategies and Compliance Boundaries for Impurity Control and Residuals
14:20-14:40
Keynote speech: Implementing Soft Sensors in Fermentation Processes: A Practical Approach to Real-Time Monitoring and Process Optimization
Speaker: Junita Dwi Andhini, Bio Farma, QA Engineer
14:40-15:00
Keynote Speech: PEG-Free LNPs for Targeted mRNA Vaccine Delivery
Speaker: Yi Yan, BTI, A*STAR, Distinguished Principal Scientist
15:00-15:20
Keynote: Harnessing Cell Surface Glycans for Therapeutics
Speaker: Andre Choo, BTI, A*STAR, Deputy Executive Director
15:20-15:40
Keynote Address: Innovative R&D Directions for Exosomes